1.
Andersen MS, Sorensen CB, Bolund L, Jensen TG: Mechanisms underlying targeted gene correction using chimeric RNA/DNA and single-stranded DNA oligonucleotides.J Mol Med 2002, 80:770-781.
2.
Liu L, Parekh-Olmedo H, Kmiec EB: The development and regulation of gene repair.Nat Rev Genet 2003, 4:679-689.
3.
Igoucheva O, Alexeev V, Yoon K: Nuclear extracts promote gene correction and strand pairing of oligonucleotides to the homologous plasmid.Antisense Nucleic Acid Drug Dev 2002, 12:235-246.
4.
Thorpe P, Stevenson BJ, Porteous DJ: Optimising gene repair strategies in cell culture.Gene Ther 2002, 9:700-702.
5.
Ferrara L, Kmiec EB: Camptothecin enhances the frequency of oligonucleotide-directed gene repair in mammalian cells by inducing DNA damage and activating homologous recombination.Nucleic Acids Res 2004, 32:5239-5248.
6.
Ferrara L, Parekh-Olmedo H, Kmiec E: Enhanced oligonucleotide-directed gene targeting in mammalian cells follwoing treatment with DNA damaging agents.Exp Cell Res 2004, 300:170-179.
7.
Essers J, van Steeg H, de Wit J, Swagemakers SM, Vermeij M, Hoeijmakers JH, Kanaar R: Homologous and non-homologous recombination differentially affect DNA damage repair in mice.EMBO J 2000, 19:1703-1710.
8.
Rice MC, Bruner M, Czymmek K, Kmiec EB: In vitro and in vivo nucleotide exchange directed by chimeric RNA/DNA oligonucleotides in Saccharomyces cerevisae.Mol Microbiol 2001, 40:857-868.
9.
Saintigny Y, Lopez BS: Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53.Oncogene 2002, 21:488-492.
10.
Olsen PA, McKeen C, Krauss S: Branched oligonucleotides induce in vivo gene conversion of a mutated EGFP reporter.Gene Ther 2003, 10:1830-1840.
11.
Hu Y, Parekh-Olmedo H, Drury M, Skogen M, Kmiec EB: Reaction parameters of targeted gene repair in Mammalian cells.Mol Biotechnol 2005, 29:197-210.
12.
Majumdar A, Puri N, Cuenoud B, Natt F, Martin P, Khorlin A, Dyatkina N, George AJ, Miller PS, Seidman MM: Cell cycle modulation of gene targeting by a triple helix-forming oligonucleotide.J Biol Chem 2003, 278:11072-11077.
13.
Brachman EE, Kmiec EB: DNA replication and transcription direct a DNA strand bias in the process of targeted gene repair in mammalian cells.J Cell Sci 2004, 117:3867-3874.
14.
Brachman EE, Kmiec EB: Gene repair in mammalian cells is stimulated by the elongation of S phase and transient stalling of replication forks.DNA Repair (Amst) 2005, 4:445-457.
15.
Saintigny Y, Rouillard D, Chaput B, Soussi T, Lopez BS: Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint.Oncogene 1999, 18:3553-3563.
16.
Janz C, Wiesmuller L: Wild-type p53 inhibits replication-associated homologous recombination.Oncogene 2002, 21:5929-5933.
17.
Yoon D, Wang Y, Stapleford K, Wiesmuller L, Chen J: P53 inhibits strand exchange and replication fork regression promoted by human Rad51.J Mol Biol 2004, 336:639-654.
18.
Seo YR, Kelley MR, Smith ML: Selenomethionine regulation of p53 by a ref1-dependent redox mechanism.Proc Natl Acad Sci U S A 2002, 99:14548-14553.
19.
Gudkov AV: Converting p53 from a killer into a healer.Nat Med 2002, 8:1196-1198.
20.
Evans AR, Limp-Foster M, Kelley MR: Going APE over ref-1.Mutat Res 2000, 461:83-108.
21.
Parekh-Olmedo H, Engstrom J, Kmiec EB: The effect of hydroxyurea and trichostatin A on targeted nucleotide exchange in yeast and mammalian cells.Annals of the New York Academy of Sciences 2003, 1002:43-56.
22.
Zhou N, Xiao H, Li TK, Nur-E-Kamal, Liu LF: DNA damage-mediated apoptosis induced by selenium compounds.J Biol Chem 2003, 278:29532-29537.
23.
Drury MD, Skogen MJ, Kmiec EB: A tolerance of DNA heterology in the mammalian targeted gene repair reaction.Oligonucleotides 2005, 15:155-171.
24.
Schwartz T, EB K: Using methyl methanesulfonate (MMS) to stimulate targeting gene repair activity in mammalian cells.Gene Therapy and Molecular Biology 2005, 9:193-202.
25.
Arnaudeau C, Lundin C, Helleday T: DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells.J Mol Biol 2001, 307:1235-1245.
26.
Parekh-Olmedo H, Ferrara L, Brachman E, Kmiec EB: Gene therapy progress and prospects: targeted gene repair.Gene Ther 2005, 12:639-646.
27.
Seo YR, Sweeney C, Smith ML: Selenomethionine induction of DNA repair response in human fibroblasts.Oncogene 2002, 21:3663-3669.
28.
Bijur GN, Briggs B, Hitchcock CL, Williams MV: Ascorbic acid-dehydroascorbate induces cell cycle arrest at G2/M DNA damage checkpoint during oxidative stress.Environ Mol Mutagen 1999, 33:144-152.
29.
Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD: Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.Science 1998, 281:1677-1679.
30.
Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW: DNA damage-induced activation of p53 by the checkpoint kinase Chk2.Science 2000, 287:1824-1827.
31.
Bertrand P, Saintigny Y, Lopez BS: p53's double life: transactivation-independent repression of homologous recombination.Trends Genet 2004, 20:235-243.
32.
Pierce EA, Liu Q, Igoucheva O, Omarrudin R, Ma H, Diamond SL, Yoon K: Oligonucleotide-directed single-base DNA alterations in mouse embryonic stem cells.Gene Ther 2003, 10:24-33.
33.
Ory K, Legros Y, Auguin C, Soussi T: Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.EMBO J 1994, 13:3496-3504.
34.
Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B, Levine AJ: Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.Cell Growth Differ 1990, 1:571-580.
35.
Susse S, Janz C, Janus F, Deppert W, Wiesmuller L: Role of heteroduplex joints in the functional interactions between human Rad51 and wild-type p53.Oncogene 2000, 19:4500-4512.
36.
Smith ML, Lancia JK, Mercer TI, Ip C: Selenium compounds regulate p53 by common and distinctive mechanisms.Anticancer Res 2004, 24:1401-1408.
37.
Wei Y, Cao X, Ou Y, Lu J, Xing C, Zheng R: SeO(2) induces apoptosis with down-regulation of Bcl-2 and up-regulation of P53 expression in both immortal human hepatic cell line and hepatoma cell line.Mutat Res 2001, 490:113-121.
38.
Caspari T: How to activate p53.Curr Biol 2000, 10:R315-R317.
39.
Liu L, Cheng S, van Brabant AJ, Kmiec EB: Rad51p and Rad54p, but not Rad52p, elevate gene repair in Saccharomyces cerevisiae directed by modified single-stranded oligonucleotide vectors.Nucleic Acids Res 2002, 30:2742-2750.
40.
Ferrara L, Kmiec EB: Targeted gene repair activates Chk1 and Chk2 and stalls replication in corrected cells.DNA Repair (Amst) 2006.
41.
Dudenhoffer C, Rohaly G, Will K, Deppert W, Wiesmuller L: Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination.Mol Cell Biol 1998, 18:5332-5342.
42.
Drury MD, Kmiec EB: Double displacement loops (double d-loops) are templates for oligonucleotide-directed mutagenesis and gene repair.Oligonucleotides 2004, 14:274-286.
43.
Cox MM, Goodman MF, Kreuzer KN, Sherratt DJ, Sandler SJ, Marians KJ: The importance of repairing stalled replication forks.Nature 2000, 404:37-41.